Zalutumumab

Zalutumumab, or HuMax-EGFr is a fully human IgG1 antibody directed towards the Epidermal Growth Factor receptor (EGFr). It is a product developed solely by Genmab using their highly advanced, state of art antibody laboratories and technology in Utrect, the Netherlands. As an IgG1 antibody, zalutumumab is a strong therapeutic due to its ability to interact with the body’s...
Read article at Wikipedia
Edit and Show details

Add or delete facts, expose empty fields, download data in JSON or RDF formats, and explore topic metadata.

Freebase Logo
What is Freebase?

Freebase is a huge collection of facts, built by people like you. Freebase connects facts in ways other sites can't, giving you new ways to explore millions of subjects.
You can help improve it!

Flag this Topic
Why do you want to flag this topic?
Freebase Attribution

Freebase data is free for use under the CC-BY license.

The original description for this topic was automatically generated from the Wikipedia article "Zalutumumab" licensed under the GNU Free Documentation License .
Learn more about Freebase licensing and attribution